Pasgemaakte inhoud

Definieer jou doelwit om deur nog meer relevante inhoud te blaai
Spring na verwante inhoud

VERKOOP-KANT

EEN VAN DIE WêRELD SE MEES
BEwonderde M&A-SPESIALISTE

Benchmark International verteenwoordig sake-eienaars wat hoogs gemotiveerd is en die volgende logiese stap met hul besighede wil neem, waaraan hulle oor baie jare 'n aansienlike hoeveelheid tyd en moeite gewy het. Of hulle poog om hul besigheid na die volgende vlak te neem, om te verlaat, of net om 'n manier te vind om hul persoonlike rykdom te diversifiseer, entrepreneurs van regoor die wêreld het staatgemaak op Benchmark International se groot span ervare professionele persone en gemotiveerde kopernetwerke om hul doelwit te bereik

Neem Die Eerste Stap

Grafstene

Keuring van transaksies

Bekyk sukses
Critical Environments ProfessionalsVerkry deurScientific Safety Alliance
Verkoper
Critical Environments Professionals
Verkryger
Scientific Safety Alliance
Nywerheid
Industriële
LimbTex Limited Acquired by Steeper (Part of Eqwal Group)Verkry deurLimbTex Limited Acquired by Steeper (Part of Eqwal Group)
Verkoper
LimbTex Limited
Verkryger
Steeper
Nywerheid
Gesondheidssorg
Medical Temps, IncVerkry deurHealth Network Advocates
Verkoper
Medical Temps, Inc
Verkryger
Health Network Advocates
Nywerheid
Gesondheidssorg
Mideast Delivery SolutionsVerkry deurSPS Health
Verkoper
Mideast Delivery Solutions
Verkryger
SPS Health
Nywerheid
Gesondheidssorg
Medius acquired by regenoldVerkry deurregenold acquires Medius
Verkoper
Medius AG
Verkryger
regenold GmbH
Nywerheid
Besigheidsprodukte en -dienste
QuadMed, Inc.Verkry deurBound Tree Medical, LLC
Verkoper
QuadMed, Inc.
Verkryger
Bound Tree Medical, LLC
Nywerheid
Gesondheidssorg
Medizina acquired by SteinVerkry deurStein acquired Medizina
Verkoper
Medizina GmbH & Co. KG
Verkryger
Stein HGS Holding GmbH (a portfolio company of IK Partners)
Nywerheid
Verbruiker, Voedsel en Kleinhandel
Demetrius Of Forty Churches, LLC, DBA Ahlers MealsVerkry deurA Private Investor
Verkoper
Demetrius Of Forty Churches, LLC, DBA Ahlers Meals
Verkryger
A Private Investor
Nywerheid
Verbruiker, Voedsel en Kleinhandel
Celtic Care (Swansea) acquired by PotensVerkry deurCeltic Care (Swansea) acquired by Potens
Verkoper
Celtic Care (Swansea) Limited
Verkryger
Potensial Ltd
Nywerheid
Gesondheidssorg
Career Pro Occupational Express, IncVerkry deurOwnershift, Inc
Verkoper
Career Pro Occupational Express, Inc
Verkryger
Ownershift, Inc
Nywerheid
Gesondheidssorg
Labplan acquired by ADDviseVerkry deurADDvise acquires Labplan
Verkoper
Labplan Limited
Verkryger
ADDvise AB Group
Nywerheid
Gesondheidssorg
SSS acquired by Calibre ScientificVerkry deurCalibre Scientific acquires SSS
Verkoper
Scientific Support Services Limited
Verkryger
Calibre Scientific, Inc
Nywerheid
Gesondheidssorg
MD Connect, Inc.Verkry deurSubjectWell
Verkoper
MD Connect, Inc.
Verkryger
SubjectWell
Nywerheid
Besigheidsprodukte en -dienste
B.L. Family Practice, P.A.Verkry deurMed First
Verkoper
B.L. Family Practice, P.A.
Verkryger
Med First
Nywerheid
Gesondheidssorg
CPS Research acquired by FuturemedsVerkry deurFutureMeds acquires CPS Research
Verkoper
Community Pharmacology Services Limited
Verkryger
Futuremeds Sp. z o.o.
Nywerheid
Gesondheidssorg
Corporate Health Ireland acquired by PAMVerkry deurPAM Group acquires Corporate Health Ireland
Verkoper
Corporate Health Ireland
Verkryger
PAM Occupational Health Services Group
Nywerheid
Gesondheidssorg
First Response (First Aid) acquired by Impact FuturesVerkry deurImpact Futures acquires First Response
Verkoper
First Response (First Aid) Ltd
Verkryger
Impact Futures
Nywerheid
Besigheidsprodukte en -dienste
Clearview Endoscopy acquired by ForesightVerkry deurForesight acquired Clearview Endoscopy
Verkoper
Clearview Endoscopy Limited
Verkryger
Foresight Group
Nywerheid
Gesondheidssorg
Ultra Clean Systems, Inc.Verkry deurGetinge AB
Verkoper
Ultra Clean Systems, Inc.
Verkryger
Getinge AB
Nywerheid
Gesondheidssorg
WeCareMD, P.C.Verkry deurPhysician Partners, LLC
Verkoper
WeCareMD, P.C.
Verkryger
Physician Partners, LLC
Nywerheid
Gesondheidssorg
Sleep die wyser

Bly op hoogte en teken aan vir e-poswaarskuwings oor verwante nuus

Ons het die afgelope 14 jaar 'n fantastiese besigheid in Arcus geskep en is gretig om geografies verder te ontwikkel en te diversifiseer, in verskillende marksektore en met nuwe kliënte. Deur by 'n markleier soos ERM aan te sluit, met so 'n sterk globale platform en markteenwoordigheid, sal hierdie aspirasies onmiddellik moontlik wees, terwyl ons verseker dat ons kliënte steeds toegang tot die allerbeste tegniese kundigheid het. Ons streef ook daarna om organisasies te help wat nog nie die potensiële hernubare energie na hul besighede kan bring ten volle besef nie, en het ambisieuse planne om dit te bereik deur ons unie met ERM, wat uiteindelik bydra tot die globale oorgang na 'n laer koolstofekonomie. *
Greg Shillabeer
Arcus Consultancy Services Limited
* translated
Ons het Benchmark betrek om te help met die verskaffing van professionele dienste in die verkoop van ons versekeringsverwante besigheid. Hulle span, en bowenal hul Deal Associate wat ons transaksie tot voltooiing hanteer het, het tydens moeilike onderhandelinge betrokke gebly. Die Deal Associate het JCS gehelp om die besigheidsverkope af te handel met 'n baie positiewe resultaat vir die eienaars. Puik werk Benchmark International! *
Allen G. Johnson
Johnson Claim Service, Inc.
* translated
“Ek en Barbara bedank julle almal vir julle pogings om by ons doelwit uit te kom.” *
Chuck Wunner
President
* translated
My prioriteit was om die maatskappy aan bekwame hande toe te vertrou. Danksy Benchmark International het ons dit suksesvol bereik, en ek sien uit daarna om met die nuwe eienaar saam te werk tydens hierdie volgende hoofstuk *
Thomas Roese
123 Autoteile GmbH & Co. KG
* translated
Benchmark International het 'n uitsonderlike werk gedoen om Kaleidico, LLC voor te berei om die markgeleenthede te ondersoek en ons dan uiteindelik deur 'n suksesvolle verkryging te lei. Ons waardeer veral die feit dat Benchmark International ons 'n breë en interessante blootstelling aan 'n verskeidenheid samesmeltings- en verkrygingsaansoekers gegee het. *
Bill Rice
Kaleidico, LLC
* translated
“Benchmark International het sy groot ervaring en kundigheid ten toon gestel om die sterk punte en sinergieë van twee bedryfsleiers bymekaar te bring. Die span by Benchmark het waarlik vyf sterre verdien vir hul hoë energie, skerp insig en leierskap om hierdie unie te fasiliteer. In vandag se komplekse mark is 'n soliede weldeurdagte strategie en uitvoering hoekom ek Benchmark se vermoë om te lewer, toevertrou en daarop geleun het.” *
Jeff Del Rossa
CEO
* translated
“Benchmark International se praktiese benadering tydens alle aspekte van die transaksieproses was fundamenteel in ons suksesvolle sluiting van transaksies.” *
Slav Stein
Founder
* translated
Benchmark International het regtig hul gewig getrek om hierdie transaksie te bewerkstellig. Ek was baie beïndruk deur elke spanlid se vasbyt om hierdie ooreenkoms oor die wenstreep te kry. Die belangrikste is dat die Benchmark-span altyd die tyd geneem het om na my bekommernisse en terugvoer te luister en was oop om aan hierdie ooreenkoms te werk met my beste belange in gedagte. Benchmark International het uiteindelik die perfekte vennoot gevind om die maatskappy se groei te eskaleer en DevelopScripts na die volgende vlak te neem. *
Mr. Rajaram
Developscripts LLC
* translated
Benchmark het die verkoopsproses betyds en naatloos gemaak. Ons het net 'n paar maande gelede na die mark gegaan en hulle het vinnig 'n uitstekende kulturele passing gevind wat my in staat sou stel om vinnig van die stuur af weg te tree terwyl ek deelneem aan toekomstige groei onder leiding van Apprio. *
Art Seypura
Canaide, Inc
* translated
Benchmark International se span was wonderlik om mee saam te werk. Van aan boord tot naby, was daar altyd iemand om mee te praat wat uiters kundig was en my beste belang in gedagte gehad het. Ek sal Benchmark International sterk aanbeveel vir enigiemand wat hul besigheid verkoop *
Grant Becker
Becker Wright Consultants Group, Inc
* translated

Verwant

Nuus en Artikels

Healthcare Services Private Equity Industry Update

In April, we published our 2024 Global Healthcare & Medical Industry Report, which covered the surging value of the healthcare market and the positive expectations regarding M&A activity and deal value for this year. As we move further into the year, we are seeing more positive private equity trends and investment strategies for the healthcare services industry, as dealmaking is now beginning to pick up momentum following a bit of a decline in Q2 of 2024. Investment pipelines are starting to build up at the same time that seller expectations are being tempered.

2024 Global Healthcare & Medical Industry Report

According to Verified Market Research, the global healthcare market will reach $665.37 billion by 2028. The healthcare sector is primarily segmented into pharmaceuticals, services, devices, and others. By application, the industry is categorized by cardiovascular, oncology, anti-infection, central nervous system, respiratory, and others.

2024 M&A Outlook

Explore the latest insights and trends shaping the 2024 M&A landscape in our newest article. Discover key strategies and predictions that could redefine business acquisitions this year. Stay informed and ahead of the curve with Benchmark International's comprehensive outlook.

M&A In The Behavioral Healthcare Services Market

Behavioral healthcare services M&A has been on the rise in recent years due to the high demand for mental and behavioral health services in the US. The behavioral healthcare market saw a 45% increase in 2022 versus the prior year and remains a fast market in early 2023.Outpatient behavioral healthcare services have become increasingly popular due to their accessibility and cost-effectiveness. As more patients seek treatment for mental and behavioral health issues, the demand for outpatient services grows. Investors are particularly interested in outpatient services that offer comprehensive care, including individual and group therapy, medication management, and community-based support services.In addition to private equity firms, strategic buyers such as healthcare systems and payers also show interest in the behavioral healthcare services market. These players want to diversify their revenue streams and expand their offerings to meet the growing mental and behavioral health services demand.Recent federal funding and investments to expand coverage and access to critical services have also increased M&A activity in the behavioral healthcare services sector. In March 2022, the US House of Representatives passed a $1.5 trillion spending package that included financial support programs to expand mental healthcare. The package granted $2.14 billion in funding to the National Institute for Mental Health (NIMH) to bolster research on the impact of the pandemic on mental health, an increase of $37 million from 2021.

2022 Digital Healthcare Industry Report

Americas: Sam Smoot at +1 (813) 898 2350 / [email protected]

Why Home Healthcare and Hospice is Getting Investor Attention

Investors are currently seeking opportunities that will allow them to invest their funds in safe-havens.

Medtech M&A On Track For Strong Second Half Of 2021

In the first half of 2021, medtech M&A deals already surpassed the total number of deals from last year, and this bustle in activity is forecast to continue through the second half of the year, as medtech companies have stockpiled billions of dollars in cash. The dollar value of deals in 2021 is also expected to far outpace that of 2020. Eleven megadeals were announced in H1, with a total deal value of around $128 billion.

The Impact of COVID-19 on Healthcare M&A

The Covid pandemic has placed us squarely in unprecedented times. We know this is not exactly news at this point. However, counter to the tenor of most pieces you've probably read on the topic during the past 12 months, this one aims to shine some light on one industry that has thrived: The US healthcare market, more specifically, healthcare M&A. Healthcare M&A has generally been a big winner in 2020 and into 2021 and it's happening at both ends of the market. Loss of life has been a sad reality of Covid, and the US did not prove to be an exception to the global impact of the disease. To combat this deadly virus and the financial disaster that reverberated from it, federal and state action has played a massive role in both the creation and distribution of vaccines, as well as seeking to gird sectors of the economy most impacted by the pandemic response, or most crucial to battling the disease. And considering the sluggish years that followed the Great Recession, the federal government has erred on the side of a more robust approach versus a more measured response from a fiscal perspective. Stimulus bills proceeded to roll out, injecting money into the economy on an unequal basis, with healthcare emerging as a clear winner.In late March of 2020, the CARES Act was signed into effect. The emergency relief bill totaled roughly $2 trillion, of which $153.5 billion was directed toward public health. This included hospitals and other health centers, drug access, telehealth, and medical supplies. These businesses essentially received free money to ramp up production and capabilities to meet the demand created by the virus. This pumped their top and bottom lines, as well as their stock prices, to all-time highs. A flood of buyers looking to get in on the trade continued to follow, with companies, both private and public, selling at levels not previously anticipated.The influx of investments led to an increase in the overall number of deals getting completed and the levels of total consideration in these deals. Healthcare technology, for example, has been a key fast stream during 2020 and early 2021, as "contactless" options for seemingly all human interactions surged (or we even mandated by government entities and actors). One might think of health tech as one "bookend" of the market – it has indeed received a lot of press, and a fair amount of investment capital has followed. Yet, at the other end of the market, savvy buyers and medical entrepreneurs have been getting together to do some equally interesting deals. Seemingly less attractive but well-placed and well-managed traditional medical practices, which act as the backbone for a strong healthcare M&A environment, are participating on the upside. Physician groups and healthcare facility consolidation were already a significant trend before the pandemic. This trend provided economies of scale that drastically increased margins and market share. Given the macro tailwinds of 2020, these roll-ups continue apace and continue to offer great buyer and seller opportunities. With a long track record of demonstrated upside – combined with a surging healthcare market – it is expected that this trend will continue, if not increase, throughout 2021. The Covid-19 pandemic was a major "Black Swan" event in the US market and the global world economy. It has not only quickly changed the way people around the world live their lives today but also has spurred healthcare professionals, entrepreneurs, and investors to re-think modus operandi, possibilities, and options across the healthcare market – and to invest accordingly. Whether you are positioned as a well-managed single or multi-office family medical practice, or if you have countless existing (or emerging) tech and/or healthcare products fast-streams, the world is presenting a host of options to consider for buyers and sellers of all stripes.

2020 Healthcare Sector Update

As we reach the middle of Q3, a look back at the past several months in the healthcare sector indicates certain key trends for the industry and how it is expected to undergo transformation into the future.

M&A In The Global Health and Life Insurance Industry

Common drivers of mergers and acquisitions in the global health and life insurance industry include the entry into new markets, access to new technologies, valuation trends, and reaction to regulatory changes. With growth strategies leading the charge, market expansion is often made possible through the acquisition of target companies that optimize product portfolios and customer bases, especially those that provide relatively easy yet quite valuable add-on opportunities, as organic growth does not come easily in the insurance space.